SOHO State of the Art Updates and Next Questions: Mini-Hyper-CVD Combinations for Older Adults: Results of Recent Trials and a Glimpse into the Future

被引:0
作者
Luskin, Marlise R. [1 ]
机构
[1] Dana Farber Canc Inst, Div Leukemia, Boston, MA 02115 USA
关键词
Acute lymphoblastic leukemia; Geriatric; Inotuzumab; Venetoclax; Chemotherapy; ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; LOW-INTENSITY CHEMOTHERAPY; ELDERLY-PATIENTS; HYPERFRACTIONATED CYCLOPHOSPHAMIDE; INOTUZUMAB OZOGAMICIN; REMISSION INDUCTION; REGIMEN; PRECURSOR; CONSOLIDATION;
D O I
10.1016/j.clml.2021.12.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Acute lymphoblastic leukemia (ALL) is an aggressive blood cancer that affects both children and adults. Although the majority of children diagnosed with ALL are now cured and outcomes are improving for younger adults, older adults diagnosed with ALL usually succumb to their disease. Traditional chemotherapy regimens are poorly tolerated and ineffective in most older adults. Recently, novel chemotherapy agents such as inotuzumab ozogamicin and venetoclax have been successfully combined with dose reduced chemotherapy (mini-hyper-CVD) with promising results. Further study is needed to define the optimal combination and sequencing of novel agents and chemotherapy for different patient populations. This review discusses the challenge of treating older adults with traditional chemotherapy, experience to date with novel agents in combination with mini-hyper-CVD, as well as future directions and unanswered questions.
引用
收藏
页码:436 / 441
页数:6
相关论文
共 40 条
[1]   Results of SWOG 1318: A Phase 2 Trial of Blinatumomab Followed By Pomp (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) Maintenance in Elderly Patients with Newly Diagnosed Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic Leukemia [J].
Advani, Anjali S. ;
Moseley, Anna ;
O'Dwyer, Kristen Marie ;
Wood, Brent ;
Fang, Min ;
Wieduwilt, Matthew J. ;
Aldoss, Ibrahim ;
Park, Jae H. ;
Klisovic, Rebecca ;
Baer, Maria R. ;
Stock, Wendy ;
Bhave, Rupali ;
Othus, Megan ;
Litzow, Mark R. ;
Stone, Richard M. ;
Erba, Harry P. .
BLOOD, 2018, 132
[2]   MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199 [J].
Benito, Juliana M. ;
Godfrey, Laura ;
Kojima, Kensuke ;
Hogdal, Leah ;
Wunderlich, Mark ;
Geng, Huimin ;
Marzo, Isabel ;
Harutyunyan, Karine G. ;
Golfman, Leonard ;
North, Phillip ;
Kerry, Jon ;
Ballabio, Erica ;
Ni Chonghaile, Triona ;
Gonzalo, Oscar ;
Qiu, Yihua ;
Jeremias, Irmela ;
Debose, LaKiesha ;
O'Brien, Eric ;
Ma, Helen ;
Zhou, Ping ;
Jacamo, Rodrigo ;
Park, Eugene ;
Coombes, Kevin R. ;
Zhang, Nianxiang ;
Thomas, Deborah A. ;
O'Brien, Susan ;
Kantarjian, Hagop M. ;
Leverson, Joel D. ;
Kornblau, Steven M. ;
Andreeff, Michael ;
Mueschen, Markus ;
Zweidler-McKay, Patrick A. ;
Mulloy, James C. ;
Letai, Anthony ;
Milne, Thomas A. ;
Konopleva, Marina .
CELL REPORTS, 2015, 13 (12) :2715-2727
[3]   Patients' age and BCR-ABL frequency in adult B-precursor ALL:: a retrospective analysis from the GMALL study group [J].
Burmeister, Thomas ;
Schwartz, Stefan ;
Bartram, Claus R. ;
Goekbuget, Nicola ;
Hoelzer, Dieter ;
Thiel, Eckhard .
BLOOD, 2008, 112 (03) :918-919
[4]   Maturation Stage of T-cell Acute Lymphoblastic Leukemia Determines BCL-2 versus BCL-XL Dependence and Sensitivity to ABT-199 [J].
Chonghaile, Triona Ni ;
Roderick, Justine E. ;
Glenfield, Cian ;
Ryan, Jeremy ;
Sallan, Stephen E. ;
Silverman, Lewis B. ;
Loh, Mignon L. ;
Hunger, Stephen P. ;
Wood, Brent ;
DeAngelo, Daniel J. ;
Stone, Richard ;
Harris, Marian ;
Gutierrez, Alejandro ;
Kelliher, Michelle A. ;
Letai, Anthony .
CANCER DISCOVERY, 2014, 4 (09) :1074-1087
[5]   Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden [J].
DeAngelo, Daniel J. ;
Advani, Anjali S. ;
Marks, David, I ;
Stelljes, Matthias ;
Liedtke, Michaela ;
Stock, Wendy ;
Goekbuget, Nicola ;
Jabbour, Elias ;
Merchant, Akil ;
Wang, Tao ;
Vandendries, Erik ;
Neuhof, Alexander ;
Kantarjian, Hagop ;
O'Brien, Susan .
BLOOD CANCER JOURNAL, 2020, 10 (08)
[6]   Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia [J].
Dhedin, Nathalie ;
Huynh, Anne ;
Maury, Sebastien ;
Tabrizi, Reza ;
Beldjord, Kheira ;
Asnafi, Vahid ;
Thomas, Xavier ;
Chevallier, Patrice ;
Nguyen, Stephanie ;
Coiteux, Valerie ;
Bourhis, Jean-Henri ;
Hichri, Yosr ;
Escoffre-Barbe, Martine ;
Reman, Oumedaly ;
Graux, Carlos ;
Chalandon, Yves ;
Blaise, Didier ;
Schanz, Urs ;
Lheritier, Veronique ;
Cahn, Jean-Yves ;
Dombret, Herve ;
Ifrah, Norbert .
BLOOD, 2015, 125 (16) :2486-2496
[7]   Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia [J].
DiNardo, Courtney D. ;
Pratz, Keith ;
Pullarkat, Vinod ;
Jonas, Brian A. ;
Arellano, Martha ;
Becker, Pamela S. ;
Frankfurt, Olga ;
Konopleva, Marina ;
Wei, Andrew H. ;
Kantarjian, Hagop M. ;
Xu, Tu ;
Hong, Wan-Jen ;
Chyla, Brenda ;
Potluri, Jalaja ;
Pollyea, Daniel A. ;
Letai, Anthony .
BLOOD, 2019, 133 (01) :7-17
[8]   Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia [J].
Fathi, Amir T. ;
DeAngelo, Daniel J. ;
Stevenson, Kristen E. ;
Kolitz, Jonathan E. ;
Asch, Julie D. ;
Amrein, Philip C. ;
Attar, Eyal C. ;
Steensma, David P. ;
Wadleigh, Martha ;
Foster, Julia ;
Connolly, Christine ;
Galinsky, Ilene ;
Devoe, Craig E. ;
Stone, Richard M. ;
Neuberg, Donna S. ;
Ballen, Karen K. .
CANCER, 2016, 122 (15) :2379-2388
[9]   Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults [J].
Foa, Robin ;
Bassan, Renato ;
Vitale, Antonella ;
Elia, Loredana ;
Piciocchi, Alfonso ;
Puzzolo, Maria-Cristina ;
Canichella, Martina ;
Viero, Piera ;
Ferrara, Felicetto ;
Lunghi, Monia ;
Fabbiano, Francesco ;
Bonifacio, Massimiliano ;
Fracchiolla, Nicola ;
Di Bartolomeo, Paolo ;
Mancino, Alessandra ;
De Propris, Maria-Stefania ;
Vignetti, Marco ;
Guarini, Anna ;
Rambaldi, Alessandro ;
Chiaretti, Sabina .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (17) :1613-1623
[10]   Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia [J].
Foa, Robin ;
Vitale, Antonella ;
Vignetti, Marco ;
Meloni, Giovanna ;
Guarini, Anna ;
De Propris, Maria Stefania ;
Elia, Loredana ;
Paoloni, Francesca ;
Fazi, Paola ;
Cimino, Giuseppe ;
Nobile, Francesco ;
Ferrara, Felicetto ;
Castagnola, Carlo ;
Sica, Simona ;
Leoni, Pietro ;
Zuffa, Eliana ;
Fozza, Claudio ;
Luppi, Mario ;
Candoni, Anna ;
Iacobucci, Ilaria ;
Soverini, Simona ;
Mandelli, Franco ;
Martinelli, Giovanni ;
Baccarani, Michele .
BLOOD, 2011, 118 (25) :6521-6528